胆管がんの世界市場 (2024～2028年)

胆管がん市場 (2024～2028年)

胆管がん市場は2023-2028年に1億3,740万米ドル分拡大し、予測期間中に8.7%のCAGRで成長すると予測されます。当レポートでは、胆管がん市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。

当レポートでは、現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。新興国市場における化学療法薬の人気拡大や、胆管がんの発症件数の増加、新薬承認などが市場を牽引しています。

当レポートでは、今後数年間の胆管がん市場の成長を促進する主な要因の1つとして、堅調な研究開発活動によるパイプライン製品の充当を挙げています。また、様々な戦略や次世代シーケンシング (NGS) ベース検査の採用が、市場の大きな需要につながります。

目次

第1章 エグゼクティブサマリー

• 市場概要

第2章 市場情勢

• 市場エコシステム
• 市場の特徴
• バリューチェーン分析

第3章 市場規模

• 市場の定義
• 市場セグメント分析
• 市場規模 (2023年)
• 市場の見通し (2023～2028年)

第4章 市場規模実績

• 胆管がんの世界市場 (2018～2022年)
• 種類別分析 (2018～2022年)
• 地域別分析 (2018～2022年)
• 国別分析 (2018～2022年)

第5章 ファイブフォース分析

• ファイブフォースの要約
• 買い手の交渉力
• 供給企業の交渉力
• 新規参入業者の脅威
• 代替品の脅威
• 競争の脅威
• 市況

第6章 市場セグメンテーション：種類別

• 市場セグメント
• 比較：種類別
• 肝外胆管がん：市場規模と予測 (2023～2028年)
• 肝内胆管がん：市場規模と予測 (2023～2028年)
• 市場機会：種類別

第7章 顧客情勢

• 顧客情勢の概要

第8章 地域別情勢

• 地域別セグメンテーション
• 地域別比較
• 北米：市場規模と予測 (2023～2028年)
• 欧州：市場規模と予測 (2023～2028年)
• アジア：市場規模と予測 (2023～2028年)
• 世界のその他の地域：市場規模と予測 (2023～2028年)
• 米国：市場規模と予測 (2023～2028年)
• ドイツ：市場規模と予測 (2023～2028年)
• 英国：市場規模と予測 (2023～2028年)
• 中国：市場規模と予測 (2023～2028年)
• 日本：市場規模と予測 (2023～2028年)
• 市場機会：地域別

第9章 促進要因・課題・機会・抑制要因

• 市場促進要因
• 市場の課題
• 促進要因と課題の影響
• 市場の機会・抑制要因

第10章 競合情勢

• 概要
• 競合情勢
• 混乱の状況
• 業界のリスク

第11章 競合分析

• 企業プロファイル
• 企業の市場ポジショニング
• AstraZeneca Plc
• BridgeBio Pharma Inc
• Bristol Myers Squibb Co.
• Hutchison China Meditech Ltd.
• Incyte Corp.
• J-Pharma Co. Ltd.
• Les Laboratoires Servier
• Merck KGaA
• RemeGen Ltd.
• Sino Biopharmaceutical Ltd.

第12章 付録

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
• Exhibits5: Executive Summary - Chart on Market Segmentation by Type
• Exhibits6: Executive Summary - Chart on Incremental Growth
• Exhibits7: Executive Summary - Data Table on Incremental Growth
• Exhibits8: Executive Summary - Chart on Company Market Positioning
• Exhibits9: Parent Market
• Exhibits10: Data Table on - Parent Market
• Exhibits11: Market characteristics analysis
• Exhibits12: Value Chain Analysis
• Exhibits13: Offerings of companies included in the market definition
• Exhibits14: Market segments
• Exhibits15: Chart on Global - Market size and forecast 2023-2028 ($ million)
• Exhibits16: Data Table on Global - Market size and forecast 2023-2028 ($ million)
• Exhibits17: Chart on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibits18: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibits19: Historic Market Size - Data Table on Global Bile Duct Cancer Market 2018 - 2022 ($ million)
• Exhibits20: Historic Market Size - Type Segment 2018 - 2022 ($ million)
• Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
• Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
• Exhibits23: Five forces analysis - Comparison between 2023 and 2028
• Exhibits24: Bargaining power of buyers - Impact of key factors 2023 and 2028
• Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
• Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
• Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
• Exhibits29: Chart on Market condition - Five forces 2023 and 2028
• Exhibits30: Chart on Type - Market share 2023-2028 (%)
• Exhibits31: Data Table on Type - Market share 2023-2028 (%)
• Exhibits32: Chart on Comparison by Type
• Exhibits33: Data Table on Comparison by Type
• Exhibits34: Chart on Extrahepatic bile duct cancer - Market size and forecast 2023-2028 ($ million)
• Exhibits35: Data Table on Extrahepatic bile duct cancer - Market size and forecast 2023-2028 ($ million)
• Exhibits36: Chart on Extrahepatic bile duct cancer - Year-over-year growth 2023-2028 (%)
• Exhibits37: Data Table on Extrahepatic bile duct cancer - Year-over-year growth 2023-2028 (%)
• Exhibits38: Chart on Intrahepatic bile duct cancer - Market size and forecast 2023-2028 ($ million)
• Exhibits39: Data Table on Intrahepatic bile duct cancer - Market size and forecast 2023-2028 ($ million)
• Exhibits40: Chart on Intrahepatic bile duct cancer - Year-over-year growth 2023-2028 (%)
• Exhibits41: Data Table on Intrahepatic bile duct cancer - Year-over-year growth 2023-2028 (%)
• Exhibits42: Market opportunity by Type ($ million)
• Exhibits43: Data Table on Market opportunity by Type ($ million)
• Exhibits44: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits45: Chart on Market share By Geographical Landscape 2023-2028 (%)
• Exhibits46: Data Table on Market share By Geographical Landscape 2023-2028 (%)
• Exhibits47: Chart on Geographic comparison
• Exhibits48: Data Table on Geographic comparison
• Exhibits49: Chart on North America - Market size and forecast 2023-2028 ($ million)
• Exhibits50: Data Table on North America - Market size and forecast 2023-2028 ($ million)
• Exhibits51: Chart on North America - Year-over-year growth 2023-2028 (%)
• Exhibits52: Data Table on North America - Year-over-year growth 2023-2028 (%)
• Exhibits53: Chart on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibits54: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibits55: Chart on Europe - Year-over-year growth 2023-2028 (%)
• Exhibits56: Data Table on Europe - Year-over-year growth 2023-2028 (%)
• Exhibits57: Chart on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibits58: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibits59: Chart on Asia - Year-over-year growth 2023-2028 (%)
• Exhibits60: Data Table on Asia - Year-over-year growth 2023-2028 (%)
• Exhibits61: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibits62: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibits63: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibits64: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibits65: Chart on US - Market size and forecast 2023-2028 ($ million)
• Exhibits66: Data Table on US - Market size and forecast 2023-2028 ($ million)
• Exhibits67: Chart on US - Year-over-year growth 2023-2028 (%)
• Exhibits68: Data Table on US - Year-over-year growth 2023-2028 (%)
• Exhibits69: Chart on Germany - Market size and forecast 2023-2028 ($ million)
• Exhibits70: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
• Exhibits71: Chart on Germany - Year-over-year growth 2023-2028 (%)
• Exhibits72: Data Table on Germany - Year-over-year growth 2023-2028 (%)
• Exhibits73: Chart on UK - Market size and forecast 2023-2028 ($ million)
• Exhibits74: Data Table on UK - Market size and forecast 2023-2028 ($ million)
• Exhibits75: Chart on UK - Year-over-year growth 2023-2028 (%)
• Exhibits76: Data Table on UK - Year-over-year growth 2023-2028 (%)
• Exhibits77: Chart on China - Market size and forecast 2023-2028 ($ million)
• Exhibits78: Data Table on China - Market size and forecast 2023-2028 ($ million)
• Exhibits79: Chart on China - Year-over-year growth 2023-2028 (%)
• Exhibits80: Data Table on China - Year-over-year growth 2023-2028 (%)
• Exhibits81: Chart on Japan - Market size and forecast 2023-2028 ($ million)
• Exhibits82: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
• Exhibits83: Chart on Japan - Year-over-year growth 2023-2028 (%)
• Exhibits84: Data Table on Japan - Year-over-year growth 2023-2028 (%)
• Exhibits85: Market opportunity By Geographical Landscape ($ million)
• Exhibits86: Data Tables on Market opportunity By Geographical Landscape ($ million)
• Exhibits87: Impact of drivers and challenges in 2023 and 2028
• Exhibits88: Overview on criticality of inputs and factors of differentiation
• Exhibits89: Overview on factors of disruption
• Exhibits90: Impact of key risks on business
• Exhibits91: Companies covered
• Exhibits92: Matrix on companies position and classification
• Exhibits93: AstraZeneca Plc - Overview
• Exhibits94: AstraZeneca Plc - Product / Service
• Exhibits95: AstraZeneca Plc - Key news
• Exhibits96: AstraZeneca Plc - Key offerings
• Exhibits97: BridgeBio Pharma Inc - Overview
• Exhibits98: BridgeBio Pharma Inc - Product / Service
• Exhibits99: BridgeBio Pharma Inc - Key offerings
• Exhibits100: Bristol Myers Squibb Co. - Overview
• Exhibits101: Bristol Myers Squibb Co. - Product / Service
• Exhibits102: Bristol Myers Squibb Co. - Key news
• Exhibits103: Bristol Myers Squibb Co. - Key offerings
• Exhibits104: Hutchison China Meditech Ltd. - Overview
• Exhibits105: Hutchison China Meditech Ltd. - Business segments
• Exhibits106: Hutchison China Meditech Ltd. - Key offerings
• Exhibits107: Hutchison China Meditech Ltd. - Segment focus
• Exhibits108: Incyte Corp. - Overview
• Exhibits109: Incyte Corp. - Product / Service
• Exhibits110: Incyte Corp. - Key offerings
• Exhibits111: J-Pharma Co. Ltd. - Overview
• Exhibits112: J-Pharma Co. Ltd. - Product / Service
• Exhibits113: J-Pharma Co. Ltd. - Key offerings
• Exhibits114: Les Laboratoires Servier - Overview
• Exhibits115: Les Laboratoires Servier - Business segments
• Exhibits116: Les Laboratoires Servier - Key offerings
• Exhibits117: Les Laboratoires Servier - Segment focus
• Exhibits118: Merck KGaA - Overview
• Exhibits119: Merck KGaA - Business segments
• Exhibits120: Merck KGaA - Key news
• Exhibits121: Merck KGaA - Key offerings
• Exhibits122: Merck KGaA - Segment focus
• Exhibits123: RemeGen Ltd. - Overview
• Exhibits124: RemeGen Ltd. - Product / Service
• Exhibits125: RemeGen Ltd. - Key offerings
• Exhibits126: Sino Biopharmaceutical Ltd. - Overview
• Exhibits127: Sino Biopharmaceutical Ltd. - Business segments
• Exhibits128: Sino Biopharmaceutical Ltd. - Key offerings
• Exhibits129: Sino Biopharmaceutical Ltd. - Segment focus
• Exhibits130: Inclusions checklist
• Exhibits131: Exclusions checklist
• Exhibits132: Currency conversion rates for US$
• Exhibits133: Research methodology
• Exhibits134: Information sources
• Exhibits135: Data validation
• Exhibits136: Validation techniques employed for market sizing
• Exhibits137: Data synthesis
• Exhibits138: 360 degree market analysis
• Exhibits139: List of abbreviations

Bile Duct Cancer Market 2024-2028

The bile duct cancer market is forecasted to grow by USD 137.4 mn during 2023-2028, accelerating at a CAGR of 8.7% during the forecast period. The report on the bile duct cancer market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing preference for chemotherapy drugs in developing countries, increasing incident of bile duct cancer, and new drug approvals.

Technavio's bile duct cancer market is segmented as below:

By Type

• Extrahepatic bile duct cancer
• Intrahepatic bile duct cancer

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the robust research and development activities fueling the pipeline as one of the prime reasons driving the bile duct cancer market growth during the next few years. Also, adoption of various strategies and next-generation sequencing (NGS) based testing will lead to sizable demand in the market.

The report on the bile duct cancer market covers the following areas:

• Bile Duct Cancer Market sizing
• Bile Duct Cancer Market forecast
• Bile Duct Cancer Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading bile duct cancer market vendors that include 3D Biomedicine Science and Technology Co. Ltd., AstraZeneca Plc, BridgeBio Pharma Inc, Bristol Myers Squibb Co., F. Hoffmann La Roche Ltd., Fresenius SE and Co. KGaA, Hutchison China Meditech Ltd., Incyte Corp., Intas Pharmaceuticals Ltd., J-Pharma Co. Ltd., Les Laboratoires Servier, Merck KGaA, NuCana plc, Pfizer Inc., RemeGen Ltd., Sanofi SA, Shanghai Miracogen Inc., Sino Biopharmaceutical Ltd., Sun Pharmaceutical Industries Ltd., and Zhongshan Hospital. Also, the bile duct cancer market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market By Geographical Landscape
  • Executive Summary - Chart on Market Segmentation by Type
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
  • Parent Market
  • Data Table on - Parent Market
• 2.2 Market characteristics
  • Market characteristics analysis
• 2.3 Value chain analysis
  • Value Chain Analysis

3 Market Sizing

• 3.1 Market definition
  • Offerings of companies included in the market definition
• 3.2 Market segment analysis
  • Market segments
• 3.3 Market size 2023
• 3.4 Market outlook: Forecast for 2023-2028
  • Chart on Global - Market size and forecast 2023-2028 ($ million)
  • Data Table on Global - Market size and forecast 2023-2028 ($ million)
  • Chart on Global Market: Year-over-year growth 2023-2028 (%)
  • Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

• 4.1 Global Bile Duct Cancer Market 2018 - 2022
  • Historic Market Size - Data Table on Global Bile Duct Cancer Market 2018 - 2022 ($ million)
• 4.2 Type segment analysis 2018 - 2022
  • Historic Market Size - Type Segment 2018 - 2022 ($ million)
• 4.3 Geography segment analysis 2018 - 2022
  • Historic Market Size - Geography Segment 2018 - 2022 ($ million)
• 4.4 Country segment analysis 2018 - 2022
  • Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary
  • Five forces analysis - Comparison between 2023 and 2028
• 5.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2023 and 2028
• 5.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• 5.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2023 and 2028
• 5.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2023 and 2028
• 5.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2023 and 2028
• 5.7 Market condition
  • Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Type

• 6.1 Market segments
  • Chart on Type - Market share 2023-2028 (%)
  • Data Table on Type - Market share 2023-2028 (%)
• 6.2 Comparison by Type
  • Chart on Comparison by Type
  • Data Table on Comparison by Type
• 6.3 Extrahepatic bile duct cancer - Market size and forecast 2023-2028
  • Chart on Extrahepatic bile duct cancer - Market size and forecast 2023-2028 ($ million)
  • Data Table on Extrahepatic bile duct cancer - Market size and forecast 2023-2028 ($ million)
  • Chart on Extrahepatic bile duct cancer - Year-over-year growth 2023-2028 (%)
  • Data Table on Extrahepatic bile duct cancer - Year-over-year growth 2023-2028 (%)
• 6.4 Intrahepatic bile duct cancer - Market size and forecast 2023-2028
  • Chart on Intrahepatic bile duct cancer - Market size and forecast 2023-2028 ($ million)
  • Data Table on Intrahepatic bile duct cancer - Market size and forecast 2023-2028 ($ million)
  • Chart on Intrahepatic bile duct cancer - Year-over-year growth 2023-2028 (%)
  • Data Table on Intrahepatic bile duct cancer - Year-over-year growth 2023-2028 (%)
• 6.5 Market opportunity by Type
  • Market opportunity by Type ($ million)
  • Data Table on Market opportunity by Type ($ million)

7 Customer Landscape

• 7.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

8 Geographic Landscape

• 8.1 Geographic segmentation
  • Chart on Market share By Geographical Landscape 2023-2028 (%)
  • Data Table on Market share By Geographical Landscape 2023-2028 (%)
• 8.2 Geographic comparison
  • Chart on Geographic comparison
  • Data Table on Geographic comparison
• 8.3 North America - Market size and forecast 2023-2028
  • Chart on North America - Market size and forecast 2023-2028 ($ million)
  • Data Table on North America - Market size and forecast 2023-2028 ($ million)
  • Chart on North America - Year-over-year growth 2023-2028 (%)
  • Data Table on North America - Year-over-year growth 2023-2028 (%)
• 8.4 Europe - Market size and forecast 2023-2028
  • Chart on Europe - Market size and forecast 2023-2028 ($ million)
  • Data Table on Europe - Market size and forecast 2023-2028 ($ million)
  • Chart on Europe - Year-over-year growth 2023-2028 (%)
  • Data Table on Europe - Year-over-year growth 2023-2028 (%)
• 8.5 Asia - Market size and forecast 2023-2028
  • Chart on Asia - Market size and forecast 2023-2028 ($ million)
  • Data Table on Asia - Market size and forecast 2023-2028 ($ million)
  • Chart on Asia - Year-over-year growth 2023-2028 (%)
  • Data Table on Asia - Year-over-year growth 2023-2028 (%)
• 8.6 Rest of World (ROW) - Market size and forecast 2023-2028
  • Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• 8.7 US - Market size and forecast 2023-2028
  • Chart on US - Market size and forecast 2023-2028 ($ million)
  • Data Table on US - Market size and forecast 2023-2028 ($ million)
  • Chart on US - Year-over-year growth 2023-2028 (%)
  • Data Table on US - Year-over-year growth 2023-2028 (%)
• 8.8 Germany - Market size and forecast 2023-2028
  • Chart on Germany - Market size and forecast 2023-2028 ($ million)
  • Data Table on Germany - Market size and forecast 2023-2028 ($ million)
  • Chart on Germany - Year-over-year growth 2023-2028 (%)
  • Data Table on Germany - Year-over-year growth 2023-2028 (%)
• 8.9 UK - Market size and forecast 2023-2028
  • Chart on UK - Market size and forecast 2023-2028 ($ million)
  • Data Table on UK - Market size and forecast 2023-2028 ($ million)
  • Chart on UK - Year-over-year growth 2023-2028 (%)
  • Data Table on UK - Year-over-year growth 2023-2028 (%)
• 8.10 China - Market size and forecast 2023-2028
  • Chart on China - Market size and forecast 2023-2028 ($ million)
  • Data Table on China - Market size and forecast 2023-2028 ($ million)
  • Chart on China - Year-over-year growth 2023-2028 (%)
  • Data Table on China - Year-over-year growth 2023-2028 (%)
• 8.11 Japan - Market size and forecast 2023-2028
  • Chart on Japan - Market size and forecast 2023-2028 ($ million)
  • Data Table on Japan - Market size and forecast 2023-2028 ($ million)
  • Chart on Japan - Year-over-year growth 2023-2028 (%)
  • Data Table on Japan - Year-over-year growth 2023-2028 (%)
• 8.12 Market opportunity By Geographical Landscape
  • Market opportunity By Geographical Landscape ($ million)
  • Data Tables on Market opportunity By Geographical Landscape ($ million)

9 Drivers, Challenges, and Opportunity/Restraints

• 9.1 Market drivers
• 9.2 Market challenges
• 9.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2023 and 2028
• 9.4 Market opportunities/restraints

10 Competitive Landscape

• 10.1 Overview
• 10.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 10.3 Landscape disruption
  • Overview on factors of disruption
• 10.4 Industry risks
  • Impact of key risks on business

11 Competitive Analysis

• 11.1 Companies profiled
  • Companies covered
• 11.2 Market positioning of companies
  • Matrix on companies position and classification
• 11.3 AstraZeneca Plc
  • AstraZeneca Plc - Overview
  • AstraZeneca Plc - Product / Service
  • AstraZeneca Plc - Key news
  • AstraZeneca Plc - Key offerings
• 11.4 BridgeBio Pharma Inc
  • BridgeBio Pharma Inc - Overview
  • BridgeBio Pharma Inc - Product / Service
  • BridgeBio Pharma Inc - Key offerings
• 11.5 Bristol Myers Squibb Co.
  • Bristol Myers Squibb Co. - Overview
  • Bristol Myers Squibb Co. - Product / Service
  • Bristol Myers Squibb Co. - Key news
  • Bristol Myers Squibb Co. - Key offerings
• 11.6 Hutchison China Meditech Ltd.
  • Hutchison China Meditech Ltd. - Overview
  • Hutchison China Meditech Ltd. - Business segments
  • Hutchison China Meditech Ltd. - Key offerings
  • Hutchison China Meditech Ltd. - Segment focus
• 11.7 Incyte Corp.
  • Incyte Corp. - Overview
  • Incyte Corp. - Product / Service
  • Incyte Corp. - Key offerings
• 11.8 J-Pharma Co. Ltd.
  • J-Pharma Co. Ltd. - Overview
  • J-Pharma Co. Ltd. - Product / Service
  • J-Pharma Co. Ltd. - Key offerings
• 11.9 Les Laboratoires Servier
  • Les Laboratoires Servier - Overview
  • Les Laboratoires Servier - Business segments
  • Les Laboratoires Servier - Key offerings
  • Les Laboratoires Servier - Segment focus
• 11.10 Merck KGaA
  • Merck KGaA - Overview
  • Merck KGaA - Business segments
  • Merck KGaA - Key news
  • Merck KGaA - Key offerings
  • Merck KGaA - Segment focus
• 11.11 RemeGen Ltd.
  • RemeGen Ltd. - Overview
  • RemeGen Ltd. - Product / Service
  • RemeGen Ltd. - Key offerings
• 11.12 Sino Biopharmaceutical Ltd.
  • Sino Biopharmaceutical Ltd. - Overview
  • Sino Biopharmaceutical Ltd. - Business segments
  • Sino Biopharmaceutical Ltd. - Key offerings
  • Sino Biopharmaceutical Ltd. - Segment focus

12 Appendix

• 12.1 Scope of the report
• 12.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 12.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 12.4 Research methodology
  • Research methodology
• 12.5 Data procurement
  • Information sources
• 12.6 Data validation
  • Data validation
• 12.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 12.8 Data synthesis
  • Data synthesis
• 12.9 360 degree market analysis
  • 360 degree market analysis
• 12.10 List of abbreviations
  • List of abbreviations